| Originator: |
|
National Patient Safety Alert - MHRA
|
 |
|
|
- Care Trusts
- Mental Health Trusts
- Specialists Trusts
- Learning Disabilities Trusts
- Mental Health & Social Care Trusts
- Ambulance Trusts
- Mental Health & Learning Disabilities Trusts
- Acute Trusts
- Community Trusts
|
|
|
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- Special Health Authorities
- Territorial CMOs in Northern Ireland, Scotland & Wales
|
| Title: |
|
Potential risk of underdosing with calcium gluconate in severe hyperkalaemia
|
| Broadcast content: |
|
This alert highlights the Adult Renal Association Clinical Practice Guidelines (2020) recommendation on calcium gluconate use to support organisations to update local policies and guidelines for the treatment of severe hyperkalaemia in adults. The MHRA has also published a Drug Safety Update article with further information.
This National Patient Safety Alert provides further background and clinical information and actions for providers.
|
| Additional information: |
|
This alert is not relevant to primary care.
|
| Action underway deadline: |
|
29-Jun-2023
|
| Action complete deadline: |
|
01-Dec-2023
|